DigitalHealth InvestorTalk Show

What are the new capabilities of modern AI and where can they be best used in healthcare to solve problems? There's been a flurry of healthcare AI startups since the arrivel of ChatGPT, and the sector is white hot with investors. What are the problem areas in healthcare that are amenible to the capabilities of generative AI? In this show we'll cover: - The capabilities of generative AI - T...

Tech can help the Silver Tsunami age in place. Here's a framework for what is needed at each level of care. Aging is the biggest demographic trend in the US and the world. There isn't enough skilled care available so tech will fill the gap. Seniors want to age in place, and there is a greater opportunity than ever to meet the needs of aging seniors in-home with technology. In this show we&...

In the show we’ll dive into: - How the employer healthtech sector is evolving - Trends at employer benefit leaders and their changing buying preferences - Signs that a consolidation wave is building And we'll answer your questions Marcus Osborne is the executive chairman of Rightmove Health, a virtual movement health company. He is a former SVP of Walmert Health. You can follow him on X. Steven Wa...

What are the changing priorities of the software budgets of the major healthcare sectors? The problems facing healthcare incumbents keep changing and so their budget strength and priorities also change. We take a look at the problems and budget strengths today for buying tech by Providers, Payers, Employers, and Pharma. In this show we'll cover: - Today's significant problems facing the different...

Digital health sectors are maturing and consolidators are circling. Have some recent acquisitions kicked off the game of musical chairs? In the show we’ll dive into: - There has been tremendous entry of innovators into healthcare since 2009 but consolidation has typically been weak - Some recent acquisitions like Virgin Pulse & HealthComp and Veradigm's acquisition of ScienceIO show that the p...

We've lived through an unprecedented period of new digital health products and companies. Consolidation follows. In the show we’ll dive into: - There has been tremendous entry of new products and companies into all the subsectors of digital health since 2009 but sector consolidation has been consistently weak - As the sector matures, we're seeing product buyers move toward the enterprise buy and s...

Why we need a new city for our biggest innovations, what a health innovation city should include, and how it's going in Vitalia In the show we’ll dive into: - What it takes to build a new health innovation city and how this new foundation will enable fast clinical trials, patient right-to-try, and much more - What's going on at Vitalia City (vitalia.city) and what is the agenda for their "pop-up c...

Americans spend more than anyone on their healthcare. There are only 4 ways to get costs down but breakthroughs are tough. In the show we’ll dive into: - The only way to cut heatlhcare costs are cut prices, cut use, reduce unnecessary services, and replace higher cost services with lower priced ones - We look at each way to cut costs with policy innovation promising to reduce unnecessary services...

Consumers have more options than ever, conglomerates are looking for weakness, what will happen to the drug store? In the show we’ll dive into: Consumers now have more choice than ever before including telehealth prescription companies like Ro and Hims that can cherry-pick the industry Amazon is re-inventing pharmacy-by-mail while CVS and Walgreens are bringing primary care clinics on premises Ind...

New tech is capturing more kinds of data, more continuous data, and data in new care settings that is transforming how we provide care. In the show we’ll dive into: How new technologies are offering a better understanding of disease - more data, more continuous data, and clinical data in more local settings. How better data is offering opportunities to improve care delivery. How rigidities like re...

Who stands to eat the most wedges of cheese from the digital health wheel? Payers, Patients, Pharma, software vendors, Providers? In the show we’ll dive into: - The digital health category is maturing as technology stops being shocking and becomes mundane - Competition heats up and differentiation fades; the different actors jocky for position - Who will win the digital health market and be the bi...

Optimal fitness and longevity are an increasingly realistic goal, a lifestyle, and a business opportunity. We discuss. In the show we’ll dive into: Is it possible to achieve optimal fitness as we age? What kind of longevity will be possible in the future? How do we monitor ourselves and maintain a healthy lifestyle? What are some goals for optimal wellness? What are the markets and business opport...

In the show we’ll dive into: How AI adds to reading and interpreting genomic information from blood or biopsy Pros & cons of “black box” vs “explainable white box” AI algorithms Where the opportunities are to diagnose and manage disease better What is holding us back from curing inflammatory & autoimmune diseases today? And we'll answer your questions Amrie Grammer, PhD is the Co-Found...

Consumers are increasingly spending their own dollars and becoming the decision makers in healthcare In the show we’ll dive into: New technologies like telehealth and smartphones have created a supply shock of healthcare options for consumers New products and business models are gaining traction But will consumer behavior change fast enough and will consumers really pay? Todd Pietri and Jarred Bre...

Not all digital health companies and strategic transactions are equal. Some have more sizzle and get more attention. In the show we’ll dive into: How does the fundraising and acquisition market look and where is it headed? What is the steak and the sizzle that wins attention for young digital health companies? How do company leaders position themselves now to get ahead? And we'll answer your q...

In the show we dive into: What are the hubs of digital health benefits solutions -- like wellness, navigation, care management, and more What do the point solutions do in response to the emergence of these marketplaces? What are the Solution Aggregators doing next, and what should we know about Accolade, Quantum, Collective, Solera, Vera Whole Health, and Virgin Pulse? And we'll answer your qu...

After an unprecedented wave of software innovation, where are digital health products creating clinical and financial value for buyers? In the show we’ll dive into: There has been a tremendous amount of software innovation in healthcare since 2009 across all subsectors But the digital health sector frequently suffers from weak product adoption We look at those markets in healthcare where digital h...

The boom of digital health venture funding has not produced the returns investors hoped. What's next? In the show we’ll dive into: What problems plague the digital health sector: higher costs, slower scaling, longer sales cycles Are there areas where the venture model works in healthcare software and services? What are the future opportunities? Sam Toole is a Partner at Primary Venture Partner...

Editor's note: there was an audio problem (low volume) for the first 6 minutes of the show. In the show we’ll dive into: - What is going on in the early-stage digital health fundraising market - How to prepare for your next fundraise and position yourself - How to figure out which investors add value Michael Kisch is the managing partner of The Range, a global health tech advisory firm, and a...

In the show we’ll dive into: The AI products and business models in healthcare that will be successful The limitations and problems of AI especially in a healthcare context The barriers to adoption that AI faces Ron Razmi, MD, is a cardiologist and venture partner at Zoi Capital and the former CEO of Acupera. He is the author of the book AI Doctor: The Rise of Artificial Intelligence in Healthcare...

In the show we’ll dive into: The changing needs of providers and payers and best ways to sell to them A fresh take on Go-To-Market Strategy for today's environment Expert use of sales enablement tools, buyer personas, value propositions, and scripting And we'll answer your questions Dutch Dwight is the VP of Business Development at Woebot and is a multi-time head of sales for digital healt...